GordonMD Global Investments
Funding rounds backed by GordonMD Global Investments.
- Funding disclosed in full
- $57.7M
- Median round
- $28.9M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Cyllene Therapeutics Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases | €33MSeries C | BiotechFrance | |||
| Rapalogix Health Develops prescription therapeutics and skincare products for cellular longevity and skin health | $20MSeries A | BiotechUnited States |